SCHEMBL9588015

SCHEMBL9588015

Cc1ccsc1C(Cl)c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.35
ADRA1D P25100 2/20 0.34
GAA P10253 3/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ACHE P22303 1/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
SLC6A3 Q01959 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2A6 P11509 1/20 0.30
CYP2B6 P20813 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9633509 0.72
SCHEMBL424538 0.71 IDO1 (0.46) ALDH1A1SMN1; SMN2ACHEIDO1TDO2
SCHEMBL11201293 0.70 ACHE (0.62) GAAALDH1A1SMN1; SMN2ACHEMEN1
SCHEMBL827163 0.69
SCHEMBL14923162 0.68
SCHEMBL7550562 0.67 ALOX5 (0.41) ALOX5KDM4ESLC6A3CYP2C19
SCHEMBL7320913 0.67 SLC6A3 (0.41) GAAALDH1A1KDM4ESMN1; SMN2POLB
SCHEMBL10357652 0.67 ESR1 (0.41) GAAALDH1A1ACHEPOLBIDO1
SCHEMBL7072983 0.64 ALOX5 (0.41) ALOX5ADRA1DALDH1A1POLBMEN1
SCHEMBL6315132 0.64 ALOX5 (0.41) ALOX5ADRA1DGAAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5177077-A Inhibitors at dopamine uptake sites, treatment of mental disorders NOVO NORDISK A/S (DK) 1993-01-05 US disclosed